title: Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro.
abstract: The effect of gamma-interferon (gamma-IFN) on the interleukin-1 alpha (IL-1 alpha) induced stimulation of urokinase-type plasminogen activator (u-PA) expression in human foreskin microvascular endothelial cells (HFMEC) and in human umbilical vein endothelial cells (HUVEC) was investigated. When gamma-IFN and IL-1 alpha were added to the cells simultaneously, gamma-IFN inhibited the IL-1 alpha induced increase in u-PA antigen production in both HFMEC and HUVEC in a dose dependent fashion, with a maximum inhibitory effect achieved between 2.0 and 20.0 U/ml of gamma-IFN. Pretreatment of HFMEC with gamma-IFN for 1 hour before addition of IL-1 alpha resulted in a significant reduction in u-PA synthesis. However, when HFMEC were pretreated for 8 hours with gamma-IFN before the addition of IL-1 alpha the reduction in u-PA production was even more significant. When gamma-IFN was added to HFMEC 1 hour after IL-1 alpha, a significant inhibition in u-PA synthesis was seen. In contrast only a slight inhibition in IL-1 alpha induced u-PA production was seen when gamma-IFN was added to the cells 8 hours after IL-1 alpha. gamma-IFN also inhibited significantly the IL-1 alpha induced increase in u-PA specific mRNA in HUVEC and HFMEC.
authors.affiliation: Dept. Diag. Haematol., Royal Melbourne Hospital, Parkville, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Wojta
authors.forename: H
authors.initials: H
authors.lastname: Zoellner
authors.forename: M
authors.initials: M
authors.lastname: Gallicchio
authors.forename: J A
authors.initials: JA
authors.lastname: Hamilton
authors.forename: K
authors.initials: K
authors.lastname: McGrath
mesh_terms: D015152:Blotting, Northern; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D007231:Infant, Newborn; D007371:Interferon-gamma / Q000494:pharmacology*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D008833:Microcirculation; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012867:Skin / Q000098:blood supply; D010959:Tissue Plasminogen Activator / Q000096:biosynthesis; D014471:Umbilical Veins; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D007375:Interleukin-1; D017395:Plasminogen Activator Inhibitor 1; D011994:Recombinant Proteins; D012313:RNA; D007371:Interferon-gamma; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator